Asthma Conference and Events

New Asthma Trials Shows Promise

press reports published today reflect that a new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage trial, making it a potential game changer for patients with moderate to severe disease, researchers said on Tuesday.

Improving Asthma Control in Patients of Hispanic & African Americans

Interview with Grace E. Hardie, PhD, RN, UCSF, SF State Associate Professor San Francisco State University Our understanding of how ethnicity influences how patients describe their asthma symptoms and how ethnicity impacts airway responsiveness is extremely limited. Ethnic influences on…

High Risk Factors in Asthma-COPD Overlap Syndrome

High Risk Factors in Asthma-COPD Overlap Syndrome: Highly Prevalent But Grossly Underappreciated By Tinka Davi, World Asthma Foundation The statistics are staggering: Every four minutes someone dies of COPD or chronic obstructive pulmonary disease. Every day nine people die from…